Is PLSE diluting shareholders?

Read three numbers together: shares outstanding over time (71.3M as of 2026-07-31), warrants that can convert into new shares (300,448 reported), and how much cash runway remains (~22.531318133106684 months). A company short on cash with live registrations is structurally likely to issue shares.

Where do these numbers come from?

SEC EDGAR only: the XBRL company-facts API for shares, warrants and cash, and filing metadata for registrations and pricings. Every figure shows its source form, and nothing here is estimated by us beyond the arithmetic stated next to it.

Why might a warrant tranche be missing from the table?

The tranche table is built from the dimensions the company tagged in its own 10-Q or 10-K XBRL. A tranche the filer chose not to dimension does not appear, and its absence proves nothing: the exhibits remain the ground truth. Everything shown carries the filing it came from.

Dilution profile // every instrument, one screen, from SEC filings

PULSE BIOSCIENCES, INC. (PLSE)

CIK 1625101 · all EDGAR filings →

Overall dilution risk

HIGHworst of 4 computed signals (offering ability)

= the worst band among the computed sub-ratings, no hidden weighting

Offering ability

HIGH$200M registered

= total registered offering amount from the fee exhibits of live registrations (bands: $1M / $20M)

one or more live registrations had no structured fee data, so the true total is AT LEAST this

Overhead supply

LOWwarrants = 0% of O/S

= warrant shares outstanding divided by current shares outstanding (bands: 20% / 50%)

warrants only; converts, ATMs and equity lines are not in free structured data, so the true overhead is AT LEAST this

Historical dilution

MEDIUM+30% O/S in 3y

= share count now vs 3 years ago (bands: 30% / 100%); a reverse split pushes this negative

Cash need

MEDIUM~22.5 months of runway

= cash vs trailing operating burn (bands: 6mo / 24mo; positive operating CF = low)

Same rating bands the category standard uses, but free, with the formula on the chip and the gaps in the data said out loud.

Shares outstanding over time

Latest: 71.3M shares as of Jul 31, 2026 (10-Q).

Cash runway

Funded — but tight

~23 months of cash · watch

Full breakdown: cash runway tool · source filing →

Warrants

Tranche	Warrants	Exercise price	Term	Notes
Warrants Issued In2024 Rights Offering	300,448	$11	5y	—

Tranches exactly as the company dimensioned them in its 10-Q filed Aug 6, 2026 →. Groupings can overlap (a “Series E and F” row is not additive with a “Series E” row), so do not sum this column. A tranche the filer did not tag is absent here, not absent from the cap table. DOWN-ROUND = the filer tagged price-protection accounting scoped to that tranche.

Warrants outstanding: 300,448 underlying shares, as reported Jun 30, 2026 (10-Q).

Reported exercise price: $11 (aggregate figure as tagged; individual tranches vary).

Balance-sheet fair value of warrants: $600,000 as of Nov 6, 2014.

Rough fully diluted estimate: 71.6M = 71.3M O/S + 300,448 warrant shares. An estimate, not a filing figure: it ignores converts, options and RSUs, and the two inputs carry different as-of dates.

Convertible notes

No convertible-note facts tagged in the 10-Q filed Aug 6, 2026. If convertible notes exist, their terms live in exhibit prose for this filer and are not parsed; absence of a tag is not proof of absence. The exhibits are the ground truth.

Registrations and offerings

Registered offering capacity on live registrations: $200.0Mfrom the structured fee exhibits; registered is not remaining, takedowns are not subtracted

S-3Feb 19, 2026$200.0M registeredfiling →

S-3MEFJul 15, 2024no structured fee exhibit in this filing (predates fee-data XBRL or fee deferred)filing →

S-3Apr 3, 2024no structured fee exhibit in this filing (predates fee-data XBRL or fee deferred)filing →

Last 12 months: 2 executed · 1 registered.

EXECUTEDAug 6, 2026Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)424B5 →

EFFECTIVEFeb 27, 2026SEC declared a registration effective — selling can beginEFFECT →

EXECUTEDFeb 19, 2026Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)424B5 →

REGISTEREDFeb 19, 2026S-3 registration — capacity to sell shares, not a sale yetS-3 →

REGISTEREDJul 15, 2024S-3MEF registration — capacity to sell shares, not a sale yetS-3MEF →

EXECUTEDJul 15, 2024Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)424B5 →

EXECUTEDJun 4, 2024Prospectus supplement priced — shares or notes (large filers: often a bond deal)424B2 →

EFFECTIVEMay 31, 2024SEC declared a registration effective — selling can beginEFFECT →

EFFECTIVEMay 3, 2024SEC declared a registration effective — selling can beginEFFECT →

REGISTEREDApr 30, 2024S-3/A registration — capacity to sell shares, not a sale yetS-3/A →

REGISTEREDApr 25, 2024S-3/A registration — capacity to sell shares, not a sale yetS-3/A →

REGISTEREDApr 23, 2024S-3/A registration — capacity to sell shares, not a sale yetS-3/A →

Full history and shelf status: offering checker · S-3 shelf checker

Source: SEC EDGAR XBRL company facts and filing metadata, fetched live and cached briefly. Share counts are cover-page figures with their form named. Warrant tranches and convertible notes come from the dimensioned facts in the latest 10-Q/10-K instance document, exactly as the company tagged them; untagged tranches and notes are absent, not disproven. Nothing on this page is manually verified and nothing is behind a login: what free data supports is shown, what it cannot support is stated. Not investment advice.

Keep going: float checker · offering calendar · short-squeeze screener · full PLSE workspace